Takeda Oncology

Takeda Oncology, a division of Takeda Pharmaceutical Company Limited, focuses on developing and delivering innovative cancer treatments. They generate revenue through the research, development, and commercialization of oncology therapies, including targeted treatments and immunotherapies. Founded in 1781, Takeda has a rich history, evolving from a traditional Japanese medicine company to a global leader in pharmaceuticals. Key milestones include the acquisition of Millennium Pharmaceuticals in 2008, which significantly bolstered their oncology portfolio. Takeda Oncology is committed to improving patient outcomes and advancing the science of cancer treatment.

Recent Posts by Takeda Oncology

1-1 of 1